MRK vs PFE
MRK 与 PFE 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | MRKMerck & Co., Inc. | PFEPfizer Inc. |
|---|---|---|
| 市值 | $321.60B | $142.66B |
| 市盈率(TTM) | 36.7 | 19.1 |
| 市净率 | 7.01 | 1.58 |
| 市销率 | 4.9x | 2.3x |
| 股息率 | 2.54% | 6.85% |
| 营收 | $65.77B(TTM) | $63.31B(TTM) |
| 营收同比增长 | 1.3% | -1.6% |
| 净利润 | $8.94B(TTM) | $7.49B(TTM) |
| 净利同比增长 | 6.6% | -3.2% |
| 每股收益(稀释) | $3.55(TTM) | $1.31(TTM) |
| 息税前利润率 | 34.2% | 16.3% |
| 净资产收益率 | 39.8% | 8.6% |
| 投入资本回报率 | 21.5% | 6.7% |
| 一年总回报 | +70.8% | +14.8% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:MRK vs PFE
| 指标 | MRK | PFE |
|---|---|---|
| 期末价值 | $33.5K | $13.3K |
| 总回报 | +235.1% | +33.2% |
| 年化收益 (CAGR) | +12.4% | +2.8% |
| 波动率 | 22.9% | 23.9% |
| 夏普比率 | 0.46 | 0.08 |
| 索提诺比率 | 0.67 | 0.11 |
| 最大回撤 | -43.4% | -59.0% |
基于 2600 个共同交易日,2016-03-30 → 2026-07-31 · 无风险利率 3.83%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)